Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
N-(6-oxo-6-(2-(((3S,5S,8R,9S,10R,12R,13S,14S,17R)-5,12,14-trihydroxy-13-methyl-17-(5-oxo-2,5-dihydrofuran-3-yl)-3-((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)hexadecahydro-1H-cyclopenta[a]phenanthren-10-yl)methylene)hydrazinyl)hexyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide
ID: ALA4439369
Chembl Id: CHEMBL4439369
PubChem CID: 155513846
Max Phase: Preclinical
Molecular Formula: C45H69N5O13S
Molecular Weight: 920.14
Molecule Type: Unknown
Associated Items: